Dirk Völkel

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Barbara Plaimauer, Klaus F. Zimmermann, Dirk Völkel et al. · Blood · 2002 · 229 citations

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours

Devalingam Mahalingam, Manish R. Patel, Jasgit C. Sachdev et al. · British Journal of Clinical Pharmacology · 2020 · 74 citations · Full text

Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>

Filza Hussain, Michael Freissmuth, Dirk Völkel et al. · Molecular Cancer Therapeutics · 2013 · 69 citations · Full text

Immunochemical determination of cellular prion proteinin plasma from healthy subjects and patients withsporadic CJD or other neurologic diseases

Dirk Völkel, Klaus F. Zimmermann, Inga Zerr et al. · Transfusion · 2001 · 66 citations

Native Versus Recombinant High-Mobility Group B1 Proteins: Functional Activity In Vitro

Klaus F. Zimmermann, Dirk Völkel, Sabrina Pable et al. · Inflammation · 2004 · 62 citations

Protein Function, Signal Transduction, Functional Activity +6